跳至主要内容
临床试验/NCT06625619
NCT06625619进行中(未招募)不适用

On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell TRansplant (HSCT) - Implementing the Evidence &Amp; Discovering New Knowledge

City of Hope Medical Center1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2024年10月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
6
试验地点
1
主要终点
Mucositis according to the World Health Organization (WHO) Scale

研究概览

简要总结

This study evaluates mucositis and other oral symptoms in patients undergoing photobiomodulation in patients undergoing hematopoietic stem cell transplantation.

详细描述

PRIMARY OBJECTIVE:

I. Examine mucositis severity, oral pain, taste changes, and xerostomia in patients undergoing PBM, a new standard of care for oral mucositis.

OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.

GROUP I: Patients have their medical records reviewed on study.

GROUP II: Nurses complete surveys on study.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PATIENTS:
  • Age: ≥ 18 years
  • Undergoing allogeneic HSCT - cases where PBM was used and cases where PBM was not used
  • Nurses who administer PBM

排除标准

  • 未提供

研究组 & 干预措施

Group I (Patients)

Patients have their medical records reviewed on study.

干预措施: Non-Interventional Study (Other)

Group II (Nurses)

Nurses complete surveys on study.

干预措施: Non-Interventional Study (Other)

结局指标

主要结局

Mucositis according to the World Health Organization (WHO) Scale

时间窗: Up to 22 days or until discharge, whichever came first

WHO scale is a combined patient-reported and clinician assessed rating scale that ranges from 0 ( no oral mucositis) to IV (Life threatening mucosistis).

Average oral pain

时间窗: Up to 22 days or until discharge, whichever came first

Patient is asked to rate their pain on a 0 - 10 scale with 0 being no pain and 10 being the worst possible pain.

Taste

时间窗: Up to 22 days or until discharge, whichever came first

Taste according to the Chemotherapy Induced Taste Alteration Scale (CiTAS) which is an 18-item scale that measures four dimensions of taste: decline in basic taste, discomfort, phantogeusia and parageusia, and general taste alterations. Items are stated on a Likert scale 1 - 5 (where 1 = no difficulty or absence of the disturbance and 5 = maximum difficulty or disturbance.

Xerostomia

时间窗: Up to 22 days or until discharge, whichever came first

Xerostomia severity (0-10 scale)

次要结局

未报告次要终点

研究者

发起方
City of Hope Medical Center
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验